Global Medical Ventilators Industry Outlook By 2033

The latest market research conducted by Future Market Insights (FMI) predicts significant growth in the Global Medical Ventilators Industry. In 2023, the market is anticipated to be valued at US$ 1.7 billion, with a projected annual growth rate of 9.1% between 2023 and 2033, ultimately surpassing the US$ 4 billion mark by 2033.

The surge in construction activities and industrialization, driven by rapid urbanization, has led to an alarming increase in carbon emissions over the past few years. Consequently, there has been a notable rise in the incidence of respiratory diseases, such as COPD and asthma, among the population. This alarming trend has created a substantial demand for medical ventilators to address respiratory health issues.

The impact of the COVID-19 pandemic has further accelerated market growth. As a result of viral infections, many patients have required ventilator support. In response, governments around the world have made significant investments in medical ventilator procurement. For instance, in April 2020, the United States government entered into a US$ 1.1 billion contract with General Health and Philips to bolster ventilator supplies. Additionally, in the same month, the United Kingdom secured 300 new ventilators from China.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-11287

The market has been witnessing technological advancements of late. The manufacturers have been enhancing the ventilators with sensors. This would ensure almost no interference from human beings. Thus, the human resource can be streamlined and directed to other important areas of the business.

Surging geriatric population across the globe is also expected to surge the sales of medical ventilators. This age group is prone to almost any kind of ailment, especially respiratory issues and cancer cases.

Thus, the FMI analysts believe that, ‘rapid urbanisation, COVID-19 pandemic, technological advancements, and a lot of other factors are expected to propel the medical ventilators market growth during the forecast period.’

Key Takeaways:

The market is expected to record a growth rate of 9.1%.
In 2023, the market valuation is expected to be at US$ 1.7 billion.
By 2033, the market value is expected to surpass US$ 4 billion.
As per the regional analysis, North America is expected to be the largest market.
The United States market is expected to grow at 6.8%.
The United Kingdom market is projected to advance at 5.8%.
China market is anticipated to surge at 14.7%.
Japan market is expected to advance at 9.1%.
South Korea market is anticipated to grow at 8%.
On the basis of product type, the critical care ventilators are expected to be the leading segment, and may surge at 8.6%.
On the basis of application, the invasive ventilators are projected to be the dominant segment, and is expected to grow at 7.5%.
Based on the end user, the hospitals segment is expected to be the leading segment.

Exploring the study’s key assumptions. Have a Conversation with the Analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-11287

Competitive Landscape

The key players operating in the medical ventilators market are focusing on product innovation. On that basis, they are looking to integrate their products with latest microprocessors. There are also huge investments being made on Research and Development, with an aim to create best quality ventilators. The manufacturers are also investing on tactical mergers and acquisitions, with a view to expand their market share. With a view to achieve sustainable goals, the manufacturers are also looking to cut down green house emissions, and make use of eco-friendly facilities. In order to make new strategic moves, the key players are also roping in some of the most astute minds who have been a part of this niche for decades.

Top players in the market:

Cardinal Health
Becton Dickinson and Company
GE Healthcare

Key developments in the medical ventilators Industry:

In October 2022, new research conducted by Cardinal Health highlights rheumatologist’s increasing confidence on biosimilars.
In January 2023, Michelle Quinn was named as the acting General Counsel for Becton, Dickinson and Company.

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-11287

Medical Ventilators Industry Segmentation

By Product: